203 related articles for article (PubMed ID: 18200518)
21. Guthrie test samples: is the problem solved?
Thomas C
N Z Bioeth J; 2004 Jun; 5(2):25-33. PubMed ID: 15597499
[TBL] [Abstract][Full Text] [Related]
22. American Academy of Pediatrics, Committee on Genetics: Issues in newborn screening.
Pediatrics; 1992 Feb; 89(2):345-9. PubMed ID: 1530685
[No Abstract] [Full Text] [Related]
23. Biobanks: oversight offers protection.
Hens K; Wright J; Dierickx K
Science; 2009 Nov; 326(5954):798-9; author reply 799. PubMed ID: 19892962
[No Abstract] [Full Text] [Related]
24. Preliminary CLIAC recommendations to regulate genetic testing.
Press RD
Mol Diagn; 2000 Sep; 5(3):245-7. PubMed ID: 11151838
[No Abstract] [Full Text] [Related]
25. Ethical, legal, and social implications of biobanks for genetics research.
Haga SB; Beskow LM
Adv Genet; 2008; 60():505-44. PubMed ID: 18358331
[TBL] [Abstract][Full Text] [Related]
26. Predictive genetic testing of minors.
Johnson A
NCSL Legisbrief; 2006; 14(19):1-2. PubMed ID: 16604754
[No Abstract] [Full Text] [Related]
27. Ethical, legal and social implications of genetic testing.
EC Expert Group
Bull Med Ethics; 2004 Dec-2005 Jan; (204):9-11. PubMed ID: 15856582
[No Abstract] [Full Text] [Related]
28. Ethical and policy issues in genetic testing and screening of children.
; ; ; ; ;
Pediatrics; 2013 Mar; 131(3):620-2. PubMed ID: 23428972
[TBL] [Abstract][Full Text] [Related]
29. IRB review and public health biobanking: a case study of the Michigan BioTrust for Health.
Mongoven A; McGee H
IRB; 2012; 34(3):11-6. PubMed ID: 22830178
[No Abstract] [Full Text] [Related]
30. Predictive genetic testing in minors for late-onset conditions: a chronological and analytical review of the ethical arguments.
Mand C; Gillam L; Delatycki MB; Duncan RE
J Med Ethics; 2012 Sep; 38(9):519-24. PubMed ID: 22403084
[TBL] [Abstract][Full Text] [Related]
31. Advances in genetics give rise to hosts of moral and legal problems.
Lawrence SV
Bull Am Coll Physicians; 1979 Sep; 2(9):588-9. PubMed ID: 11663100
[No Abstract] [Full Text] [Related]
32. [Ethical problems presented by collections of biological material and associated data: "biobanks", "bioethics"].
France. Comite consultatif national d'ethique pour les sciences de la vie et de la sante
J Int Bioethique; 2005; 16(3-4):141-51. PubMed ID: 17058808
[No Abstract] [Full Text] [Related]
33. The nursing perspective: genetic screening and testing.
Fibison WJ
J Sch Nurs; 1993 Dec; 9(4):16-21, 23-4; quiz 22. PubMed ID: 8124005
[TBL] [Abstract][Full Text] [Related]
34. American Academy of Pediatrics Committee on Genetics: Newborn screening fact sheets.
Pediatrics; 1989 Mar; 83(3):449-64. PubMed ID: 2919149
[No Abstract] [Full Text] [Related]
35. Biobanks: simplifying consent.
Knoppers BM
Nat Rev Genet; 2004 Jul; 5(7):485. PubMed ID: 15243995
[No Abstract] [Full Text] [Related]
36. Public interest in genetics and genetics in the public interest.
Holtzman NA
Am J Med Genet; 1980; 5(4):383-9. PubMed ID: 7395918
[No Abstract] [Full Text] [Related]
37. Pediatric research and the return of individual research results.
Avard D; Sénécal K; Madadi P; Sinnett D
J Law Med Ethics; 2011; 39(4):593-604. PubMed ID: 22084845
[TBL] [Abstract][Full Text] [Related]
38. Neonatal genetic testing is more than screening.
Kenner C; Lewis JA; Pressler JL; Little CM
Crit Care Nurs Clin North Am; 2008 Jun; 20(2):233-7, vii. PubMed ID: 18424352
[TBL] [Abstract][Full Text] [Related]
39. A proposal for a model of informed consent for the collection, storage and use of biological materials for research purposes.
Porteri C; Borry P
Patient Educ Couns; 2008 Apr; 71(1):136-42. PubMed ID: 18243633
[TBL] [Abstract][Full Text] [Related]
40. In that case. A multi-national pharmaceutical company wishes to recruit some of your patients to a pharmaco-genetic study. Response.
Holloway JW
N Z Bioeth J; 2002 Jun; 3(2):29-30. PubMed ID: 15587497
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
